The Siberian Scientific Medical Journal / Key word: , tyrosine kinase inhibitors
CLINICAL MEDICINE
The results of 12 years treatment of patients in late chronic phase of chronic myeloid leukemia by tyrosine kinase inhibitors after failure IFN-α
Lazareva O.V., Turkina A.G., Gusarova G.A., Chelysheva E.Yu., Zakharova E.S., Shukhov O.A., Bykova A.V., Goryacheva S.R., Kolosheinova T.I., Ivanova T.V., Tishchenko I.A., Kulikov S.M.
Long term results of combined treatment with imatinib and interferon in patients with the newly diagnosed chronic myeloid leukemia in chronic phase
Vinogradova O.Yu., Turkina A.G., Chelysheva E.Yu., Gusarova G.A., Kolosheinova T.I., Kolosova L.Yu., Goryacheva S.R., Vakhrusheva M.V., Khoroshko N.D.
Long-term results of therapy by dasatinib and features analysis of the pleural effusion course in patients at late chronic phase of chronic myeloid leukemia after imatinib treatment failure
Abdullaev A.O., Chelysheva E.Yu., Turkina A.G., Lazareva O.V., Kuznetsov S.V., Ivanova T.V., Gusarova G.A., Goryacheva S.R., Vorontsova A.V., Vinogradova O.Yu., Bykova A.V., Shukhov O.A.